NAII

Business Context and Reporting Period

Company: Natural Alternatives International, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 1999 (First Quarter of Fiscal 2000)
Business Overview: The Company manufactures and distributes nutritional supplements. The reporting period reflects a strategic shift toward international markets (Europe and Asia) to offset declining domestic sales driven by increased competition and reduced industry demand.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 10.1% ($1.7 million) year-over-year. Domestic sales fell approximately $2.6 million due to price competition and reduced demand for herbal products. This was partially offset by a 26.7% increase in international sales to $5.7 million.
• Margin Compression: Gross margin dropped from 27.4% to 20.9%. Cost of goods sold rose to 79.1% of sales due to depressed market prices, increased quality control costs (GMP compliance), and higher manufacturing overhead.
• Expense Growth: Selling, general, and administrative (SG&A) expenses increased to $2.8 million (18.6% of sales) from $2.2 million (12.8% of sales). Increases were driven by fixed costs, IT infrastructure upgrades, unfavorable lease arrangements, and legal fees.
• Profitability: Net income plummeted 94.3% to $87,000. The effective tax rate increased significantly to 74.7% due to the consolidation of foreign entities.
• Cash Flow: Operating cash flow decreased to $1.4 million, impacted by lower net income and a $706,000 increase in accounts receivable, though partially offset by a $646,000 reduction in inventory.

Guidance, Outlook, and Risks

Management Commentary and Outlook

• Strategic Focus: Management expects continued expansion into international markets to diversify geographic distribution.
• Capital Expenditures: The Company anticipates spending approximately $4.0 million in Fiscal 2000 on manufacturing quality improvements and vertical integration (packaging/labeling). These are expected to be funded by new term notes.
• Financing Updates:
  • On October 4, 1999, the Company replaced a $3.0 million line of credit with $9.0 million in new financing ($5.0 million revolving line, $4.0 million term note).
  • On November 9, 1999, a $2.5 million five-year term note was secured for working capital.

Risks and Contingencies

• Customer Concentration: Four customers accounted for 70% of sales in Q1 1999. The loss of any single major customer could materially impact revenue.
• Year 2000 (Y2K) Issues: While the Company believes its systems are compliant, it faces risks from third-party service providers (utilities, shipping, banking). Disruptions could impact operations. Estimated remaining Y2K costs are $150,000 for Fiscal 2000.
• Related Party Transactions: The Company wrote off $39,000 in receivables from a customer with prior equity ownership by directors/officers during the quarter.
• Market Risks: Exposure to interest rate fluctuations on money market funds and foreign currency exchange rates, though management deems these impacts immaterial.

Investor Verification Checklist

• Customer Concentration: Verify the stability of the top four customers representing 70% of revenue.
• Debt Covenants: Confirm continued compliance with financial covenants on the new $9.0 million credit facility and $2.5 million term note.
• Margin Recovery: Monitor if gross margins can recover from 20.9% as international sales volume increases and domestic competition stabilizes.
• Capital Expenditure Execution: Track the $4.0 million planned CapEx for vertical integration and its impact on future operating leverage.
• Y2K Contingencies: Assess any operational disruptions from third-party vendors as the calendar turns to 2000.